<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/b20db0d9ec224ca9ade49b26500b826e/pixel?tag=ViewContent&amp;noscript=1">
Do Vitamin E and Selenium Supplements Increase the Risk of Prostate Cancer

Last updated: January-30,2023

Do Vitamin E and Selenium Supplements Increase the Risk of Prostate Cancer?

The following blog by Gene Bruno, MS, MHS, RH(AHG) was written in response to an article published on Yahoo on November 29, 2021. The article entitled "Taking Too Much of This Supplement Makes Your Cancer Risk Soar," cites the results of a 2014 study published in the Journal of the National Cancer Institute which found that taking too much selenium and vitamin E raised the risk of being diagnosed with cancer.

A study published in 2014 suggests that vitamin E and selenium supplementation may increase the risk of prostate cancer in men. So, does this mean that men should avoid taking vitamin E and selenium supplements? Don’t throw your supplement bottles away yet. Let’s take a broader look at the research.

Gene Bruno - Web-Banner - Free Price Quote

The SELECT Study

A 2008 study [i] called “Selenium and Vitamin E Cancer Prevention Trial" (SELECT) involved 35,533 men randomly assigned to receive either: 1) selenium (L-(+)-Selenomethionine) plus synthetic vitamin E (dl-alpha-tocopheryl acetate), 2) selenium plus placebo, 3) synthetic vitamin E plus placebo, or 4) two placebos. When originally published in 2008, the results indicated that after almost five and half years, no significant differences were observed between any of the groups in relation to prostate cancer risk.

A 2011 Analysis of the SELECT Study

However, an analysis of the study’s participants published in JAMA [ii] in 2011 indicated that synthetic vitamin E supplements alone were associated with a 17% increase in the risk of prostate cancer, but that no increase in risk was observed in the combination selenium-vitamin E group.

A 2014 Analysis of the SELECT Study

Subsequently, a case-cohort study published in 2014 [iii] analyzed data from 3,117 men in the SELECT study to determine if there were any additional findings. Here were the results:

  • In the absence of supplementation, selenium was not associated with prostate cancer risk.
  • Selenium supplementation (combined selenium only and selenium + vitamin E arms) had no effect among men with low selenium status but increased the risk of high-grade prostate cancer among men with higher selenium status.
  • Vitamin E supplementation (alone) had no effect among men with high selenium status but increased the risks of total, low-grade, and high-grade prostate cancer among men with lower selenium status.

Okay, now let’s look at some other research.

Selenium Studies with Different Results

Let’s take a look at a case-control study [iv] within a prospective study of over 50,000 male health professionals in the U.S. Results were that there was a significant inverse relationship between selenium status in the body and the incidence of prostate cancer cell development. Individuals whose selenium status was consistent with an average dietary intake of 159 mcg/day of selenium daily had a 65% lower incidence of risk of prostate cancer cell development compared to those whose selenium status was consistent with an average intake of 86 mcg/day. Similar results were seen in other studies that examined selenium intake and the incidence of cancer cells from the lung [v] [vi] and liver.[vii]

Vitamin E Studies with Different Results

A placebo-controlled intervention study that was designed to look at the effect of vitamin E supplementation on lung cancer development noted a 34% reduction in the incidence of prostate cancer in smokers given daily supplements of 37.5 IU/day synthetic vitamin E.[viii] A meta-analysis that combined the results of this study with three other randomized controlled trials associated vitamin E supplement use with a 15% lower risk of prostate cancer.[ix]

Shedding Some Light on These Studies

Confused? If so, I’ll try to shed some light on these studies.

In my opinion, what the JAMA analysis really shows is that men should take selenium with their vitamin E. In fact, the JAMA analysis is reminiscent of the flawed 1994 study in which smokers using beta-carotene were thought to be at a greater risk of lung cancer,[x] although a more thorough follow-up analysis which looked at the diets and other dietary supplements taken, revealed that the smokers' actual danger was due to low total antioxidant levels; not to the fact that they took beta-carotene.[xi] This makes sense given the fact that antioxidants function interdependently, and so should be taken together. This is consistent with prior comments from Dr. Duffy MacKay of Council for Responsible Nutrition (CRN) about the JAMA analysis: "This reinforces the theory that vitamins work synergistically and that drug-like trials of nutrients, when used in isolation from other nutrients, may not be the most appropriate way to study them." [xii]

But what about the 2014 analysis of the SELECT study which showed an increase in prostate cancer risk in people supplementing with 1) selenium alone or in combination with vitamin E when they already had higher levels of selenium, or 2) vitamin E when they had low levels of selenium?

From my perspective, this is also a clear indication that nutrients like selenium and vitamin E should be taken in reasonable doses, without taking too much of any single one. Taking these nutrients together makes sense, but they need to be taken in the right balance. In my opinion (based on other research), appropriate doses are up to 100 IU (67 mg) of vitamin E, and up to 100 mcg of selenium.



[i] Scott M. Lippman SM, Klein EA, Goodman PJ, et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301(1):39-51. Published online December 9, 2008. doi: 10.1001/jama.2008.864.

[ii] Klein IM, Thompson Jr CM, Tangen JJ, et al. Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306(14):1549-1556.

[iii] Kristal AR, Darke AK, Morris JS, et al. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar;106(3):djt456.

[iv] Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90(16):1219-1224.

[v] Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J Epidemiol. 1998;148(10):975-982.

[vi] Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev. 2004;13(5):771-778.

[vii] Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol. 1999;150(4):367-374..

[viii] Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90(6):440-446.

[ix] Alkhenizan A, Hafez K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Ann Saudi Med. 2007;27(6):409-414.

[x] Authors not listed. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029–35

[xi] Wright ME, Mayne ST, Stolzenberg-Solomon RZ, et al. Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol. 2004;160(1):68-76

[xii] JAMA Study Links Vitamin E, Prostate Cancer. Natural Product Insider. Retreived October 12, 2011 from http://www.naturalproductsinsider.com.

December 1st, 2021

About the Author:

Gene Bruno

Gene Bruno, MS, MHS, RH(AHG) - Mr. Bruno possesses over 43 years of dietary supplement industry experience. With a Master's degree in nutrition and a second Master's degree in herbal medicine, he has a proven track record of formulating innovative, evidence-based dietary supplements. Mr. Bruno currently serves as both the Senior Director of Product Innovation at Twinlab Corporation and Professor of Nutraceutical Science at Huntington University of Health Sciences.